NHS

News

NICE backs new drugs for Crohn's disease, lymphoma

Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.

Digital

Tech for good: AI agents critical to improving NHS services

How NHS Trusts are harnessing the latest AI solutions to optimise the experience for their employees and care on behalf of patients.

News

Scientist working in a laboratory with apparatus

Charities call for shake-up in UK rare disease R&D

LifeArc and Genetics Alliance UK have issued a call to the government to remove obstacles impeding R&D into rare diseases.

News

UK pharma has concerns about the new NHS 10-year plan

The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.

News

NICE relents on Takeda colorectal cancer drug Fruzaqla

Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones.

News

The NHS 10 Year Plan arrives – what are the highlights?

After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS.

NICE backs new drugs for Crohn's disease, lymphoma

Tech for good: AI agents critical to improving NHS services

Charities call for shake-up in UK rare disease R&D

UK pharma has concerns about the new NHS 10-year plan

NICE relents on Takeda colorectal cancer drug Fruzaqla

The NHS 10 Year Plan arrives – what are the highlights?

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

NHS

Editor's Picks